The scientist’s investigation covers issues in Biochemistry, Stereochemistry, Receptor, Adenosine receptor and Binding site. Stefano Moro works mostly in the field of Stereochemistry, limiting it down to concerns involving Structure–activity relationship and, occasionally, Radioligand Assay. His study in Amino acid extends to Receptor with its themes.
His study in Adenosine receptor is interdisciplinary in nature, drawing from both G protein-coupled receptor, Adenosine, Ligand, Chemical synthesis and Carboxamide. His Binding site research includes themes of Protein structure and Biophysics. As a part of the same scientific study, Stefano Moro usually deals with the Docking, concentrating on Drug discovery and frequently concerns with Computational biology.
Stereochemistry, Receptor, Molecular model, Adenosine receptor and Biochemistry are his primary areas of study. His research integrates issues of Structure–activity relationship, Chemical synthesis and DNA in his study of Stereochemistry. Many of his studies involve connections with topics such as Pharmacophore and Receptor.
His study explores the link between Molecular model and topics such as Docking that cross with problems in Ligand. His Adenosine receptor research is multidisciplinary, relying on both Adenosine, Potency, Xanthine, Selectivity and Pharmacology. His work carried out in the field of G protein-coupled receptor brings together such families of science as Biophysics, Computational biology and Binding site.
Stefano Moro focuses on Molecular dynamics, Computational biology, Stereochemistry, Adenosine receptor and Molecular model. His Molecular dynamics research is multidisciplinary, incorporating elements of Protein ligand, Molecule, Chemical physics and Ligand. His Computational biology study incorporates themes from Molecular recognition, In silico and Drug discovery.
His studies in Stereochemistry integrate themes in fields like Alkyl and Amide. His Adenosine receptor study is related to the wider topic of Receptor. Stefano Moro combines subjects such as Moiety, Docking and Antagonist with his study of Molecular model.
Stefano Moro mainly focuses on Molecular dynamics, Molecular model, Ligand, Stereochemistry and Computational biology. He focuses mostly in the field of Molecular model, narrowing it down to topics relating to Drug discovery and, in certain cases, Biochemical engineering and Virology. His studies deal with areas such as Apoptosis, Structure–activity relationship and Adenosine receptor as well as Stereochemistry.
His Adenosine receptor research integrates issues from Wild type and Potency. His study looks at the relationship between Binding site and topics such as Biophysics, which overlap with Receptor. Receptor is a subfield of Biochemistry that he explores.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
Sirio Dupont;Anant Mamidi;Michelangelo Cordenonsi;Marco Montagner.
Cell (2009)
Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery
Santiago Vilar;Giorgio Cozza;Stefano Moro.
Current Topics in Medicinal Chemistry (2008)
The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit.
Anna Raffaello;Diego De Stefani;Davide Sabbadin;Enrico Teardo.
The EMBO Journal (2013)
Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
An-Hu Li;Stefano Moro;Nancy Forsyth;Neli Melman.
Journal of Medicinal Chemistry (1999)
DNA Binding Site Selection of Dimeric and Tetrameric Stat5 Proteins Reveals a Large Repertoire of Divergent Tetrameric Stat5a Binding Sites
Elisabetta Soldaini;Susan John;Stefano Moro;Julie Bollenbacher.
Molecular and Cellular Biology (2000)
Toward the rational design of protein kinase casein kinase-2 inhibitors.
Stefania Sarno;Stefano Moro;Flavio Meggio;Giuseppe Zagotto.
Pharmacology & Therapeutics (2002)
USP15 is a deubiquitylating enzyme for receptor-activated SMADs
Masafumi Inui;Andrea Manfrin;Anant Mamidi;Graziano Martello.
Nature Cell Biology (2011)
Human P2Y1 Receptor: Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition Sites
Stefano Moro;Danping Guo;Emidio Camaioni;José L. Boyer.
Journal of Medicinal Chemistry (1998)
Progress in the pursuit of therapeutic adenosine receptor antagonists.
Stefano Moro;Zhan-Guo Gao;Kenneth A. Jacobson;Giampiero Spalluto.
Medicinal Research Reviews (2006)
Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview.
Veronica Salmaso;Stefano Moro.
Frontiers in Pharmacology (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Würzburg
National Institutes of Health
University of Padua
University of Padua
University of Bologna
University of Ferrara
University of Padua
University of Ferrara
Gwangju Institute of Science and Technology
University of Padua
McGill University
Pennsylvania State University
Technion – Israel Institute of Technology
University of Malaga
Duke University
University of Kentucky
Duke University
New York Medical College
University of Colorado Denver
University of Southern California
University of Seville
University College London
Amgen (United States)
Harvard University
Fudan University
KU Leuven